Type of leukemia-Acute Myeloid Leukemia (AML) Page 2 Posts on Medivizor
Navigation Menu

Type of leukemia-Acute Myeloid Leukemia (AML) Posts on Medivizor

Combining pracinostat and azacitidine to treat older patients with newly diagnosed acute myeloid leukemia

Posted by on Apr 15, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of the combination of pracinostat and azacitidine in patients aged over 65 with newly diagnosed acute myeloid leukemia. This study concluded that this combination is a safe and effective for treating this group of patients.   Some background Pracinostat is a new drug that...

Read More

Allogenic hematopoietic stem cell transplant for patients with unresponsive acute myeloid leukemia

Posted by on Mar 20, 2019 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the effectiveness of allogeneic hemopoietic stem cell transplant (alloHSCT) in patients with unresponsive acute myeloid leukemia. This study concluded that alloHSCT is the best treatment option for these patients. Some background Patients with unresponsive acute myeloid leukemia (AML) are those...

Read More

Could hyperbaric oxygen therapy improve umbilical cord blood transplantation outcomes?

Posted by on Mar 20, 2019 in Leukemia | 0 comments

In a nutshell This study examined if hyperbaric oxygen therapy is safe and can improve outcomes in umbilical cord blood transplantation. This study concluded that the use of hyperbaric oxygen therapy before umbilical cord blood transplantation is safe and can improve outcomes in certain patients.   Some background Stem cells allow the production...

Read More

Is venetoclax with decitabine or azacitidine effective in treating elderly patients with acute myeloid leukemia?

Posted by on Feb 16, 2019 in Leukemia | 0 comments

In a nutshell This study examined If venetoclax (Venclexta) with decitabine (Dacogen) or azacitidine (Vidaza) is effective in treating elderly patients with acute myeloid leukemia (AML).  This study concluded that venetoclax with decitabine or azacitidine could be an effective treatment in these patients.  Some background Acute...

Read More

Searching for patients with relapsed or unresponsive acute myeloid leukemia to test a new treatment

Posted by on Jan 2, 2019 in Leukemia | 0 comments

In a nutshell This trial is examining the effectiveness of a new drug called uproleselan for patients with acute myeloid leukemia (AML). The main outcome to be measured will be overall survival. This study is being conducted in the United States. The details Acute myeloid leukemia (AML) is a cancer of the bone marrow. It leads to an abnormal immune...

Read More

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants

Posted by on Dec 15, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to identify risk factors of tiredness in children treated for leukemia and lymphoma or who received a stem cell transplant. Researchers found that older age and active treatment were risk factors for developing severe tiredness in these patients. Some background Cancer treatment leads to severe tiredness (fatigue) over...

Read More

Tiredness in children and teenagers with leukemia/lymphoma and stem cell transplants.

Posted by on Dec 15, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to identify risk factors of tiredness in children treated for leukemia and lymphoma or who received a stem cell transplant. Researchers found that older age and active treatment were risk factors for developing severe tiredness in these patients. Some background Cancer treatment leads to severe tiredness (fatigue) over...

Read More

Survival from transplant of donor bone marrow versus donor blood sample in leukemia treatment

Posted by on Dec 12, 2018 in Leukemia | 0 comments

In a nutshell This study compared the safety and effectiveness of donor peripheral blood (PB) with bone marrow (BM) transplant in the treatment of leukemia. Researchers found that bone marrow transplants are safer and more effective in the treatment of leukemia. Some background Leukemia is a cancer of the bone marrow. It may lead to abnormal immune...

Read More

Do ACE inhibitors help with anthracycline-induced cardiotoxicity in leukemia and lymphoma?

Posted by on Dec 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study aimed to investigate if enalapril influences anthracycline-induced cardiotoxicity in children with leukemia and lymphoma. This study concluded that enalapril has a role in reducing anthracycline-induced cardiotoxicity in these patients. Some background Anthracyclines are a class of chemotherapy drugs that can be used for...

Read More